Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $7.88 Million |
|---|---|
| Enterprise Value | $13.25 Million |
| Earnings per Share | $-0.03 |
| Beta | -4.25 |
| Outstanding Shares | 136,036,016 |
| P/E Ratio | -4.26 |
|---|---|
| PEG | 124.92 |
| Price to Sales | - |
| Price to Book Ratio | -0.06 |
| Enterprise Value to Revenue | 6.26 |
| Enterprise Value to EBIT | -7.07 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -0.66 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company...